Indicate the irreversible MAO inhibitor, which is a hydrazide derivative:

Questions 213

ATI RN

ATI RN Test Bank

Effects of Pharmacological Treatments on Clients Across a Lifespan Questions

Question 1 of 5

Indicate the irreversible MAO inhibitor, which is a hydrazide derivative:

Correct Answer: D

Rationale: In this question, the correct answer is D) Phenelzine. Phenelzine is an irreversible MAO inhibitor that belongs to the hydrazide derivative class of drugs. MAO inhibitors work by blocking the activity of the enzyme monoamine oxidase, which plays a role in the breakdown of neurotransmitters like serotonin, norepinephrine, and dopamine. A) Moclobemide is a reversible MAO inhibitor, not an irreversible one. It does not belong to the hydrazide derivative class. B) Selegiline is a selective irreversible MAO-B inhibitor, not a non-selective irreversible MAO inhibitor like Phenelzine. C) Tranylcypramine is another non-selective irreversible MAO inhibitor, but it is not a hydrazide derivative. Understanding the classification of MAO inhibitors is crucial for healthcare professionals when prescribing these medications to clients across the lifespan. Phenelzine, as an irreversible MAO inhibitor, has implications for dietary restrictions and potential drug interactions that need to be carefully managed to avoid adverse effects. It is essential for healthcare providers to have a solid grasp of the pharmacological properties of these medications to ensure safe and effective treatment for their clients.

Question 2 of 5

The mechanism of fluoxetine action includes:

Correct Answer: D

Rationale: The correct answer is D) All of the above. Fluoxetine, a commonly prescribed selective serotonin reuptake inhibitor (SSRI), works by selectively inhibiting the reuptake of serotonin in the central nervous system (CNS). This action leads to increased serotonin levels in the synaptic cleft, which is associated with improved mood and decreased symptoms of depression and anxiety. Option A is incorrect because fluoxetine does not have a significant effect on norepinephrine or dopamine function in the CNS. While some SSRIs may have minor effects on these neurotransmitters, fluoxetine is primarily focused on serotonin. Option C is also incorrect because fluoxetine does have some binding to other receptors, including cholinergic, histaminic, and alpha-adrenergic receptors. However, its primary mechanism of action is the selective inhibition of serotonin reuptake. In an educational context, understanding the mechanisms of action of pharmacological treatments like fluoxetine is crucial for healthcare professionals working with clients across the lifespan. Knowing how a medication works can help in making informed decisions about treatment options, monitoring for effectiveness and side effects, and educating clients and their families about the expected outcomes of therapy. This knowledge is fundamental in providing safe and effective care to clients experiencing mental health disorders.

Question 3 of 5

Anxiolytic dosage reduction is recommended:

Correct Answer: D

Rationale: The correct answer is D) All of the above. Anxiolytic dosage reduction is recommended in patients taking cimetidine, patients with hepatic dysfunction, and elderly patients due to various factors that can affect the metabolism and clearance of anxiolytic medications. In patients taking cimetidine, there is a potential for drug interactions as cimetidine can inhibit the metabolism of anxiolytics, leading to increased levels of the medication in the body and an increased risk of side effects. Patients with hepatic dysfunction may have impaired liver function, which can affect the metabolism and clearance of anxiolytics. Lowering the dosage helps prevent accumulation of the drug and reduces the risk of toxicity in these patients. Elderly patients often experience changes in metabolism and clearance of medications due to age-related physiological changes. As a result, they may be more sensitive to the effects of anxiolytics, necessitating lower dosages to prevent adverse reactions. In an educational context, understanding the need for dosage adjustments in specific patient populations is crucial for safe and effective pharmacological treatment. Healthcare providers must consider individual patient factors such as age, liver function, and concomitant medications to optimize therapy and minimize the risk of adverse effects. This knowledge helps ensure quality care and patient safety across the lifespan.

Question 4 of 5

Limitation of buspirone is:

Correct Answer: B

Rationale: In this scenario, the correct answer is B) An extremely slow onset of action is a limitation of buspirone. Buspirone is an anxiolytic medication commonly used to treat anxiety disorders. Its slow onset of action is a significant limitation because it may take several weeks for the full therapeutic effects to be felt by the client. This delay can be frustrating for both the client and the healthcare provider, especially when compared to other anti-anxiety medications that provide more immediate relief. Option A) A low therapeutic index is incorrect because buspirone actually has a high therapeutic index, meaning the difference between a therapeutic dose and a toxic dose is relatively wide. This characteristic makes it safer in terms of overdose risk. Option C) A high potential of development of physical dependence is incorrect because buspirone is not associated with physical dependence or withdrawal symptoms like some other medications used to treat anxiety, such as benzodiazepines. Option D) Impairment of mentation or motor functions during working hours is incorrect because buspirone is known for causing minimal sedation or cognitive impairment compared to other medications like benzodiazepines, making it a preferred choice for clients who need to remain alert and functional during the day. Educationally, understanding the limitations of pharmacological treatments like buspirone is crucial for healthcare providers to make informed decisions when choosing the most appropriate medication for their clients. Knowing the specific characteristics of each medication allows for personalized treatment plans that consider factors such as onset of action, side effects, and potential risks. By grasping these nuances, healthcare providers can optimize client care and outcomes.

Question 5 of 5

Which of the following agents is a respiratory analeptic?

Correct Answer: C

Rationale: In the context of pharmacological treatments, understanding the classification and specific actions of different agents is crucial for healthcare professionals. In this question, the correct answer is C) Bemegride, which is a respiratory analeptic. Bemegride is a central nervous system stimulant that acts primarily as a respiratory analeptic by stimulating the respiratory centers in the brainstem. It is used to treat respiratory depression, especially in cases of drug overdose or poisoning where respiratory function is compromised. Now, let's analyze why the other options are incorrect: A) Piracetam: Piracetam is a nootropic agent that is used to enhance cognitive function and memory, not a respiratory analeptic. B) Sydnocarb: Sydnocarb is a psychostimulant drug used to treat attention deficit hyperactivity disorder (ADHD) and narcolepsy, not a respiratory analeptic. D) Pantocrin: Pantocrin is a dietary supplement derived from deer antlers and is claimed to have various health benefits, but it is not a respiratory analeptic. Educational context: Understanding the specific pharmacological actions of different agents is essential for healthcare professionals to make informed decisions in clinical practice. It is important to be able to differentiate between different drug classes and their uses to provide safe and effective care to patients across the lifespan. This question highlights the importance of knowledge about respiratory analeptics and their role in managing respiratory depression.

Access More Questions!

ATI RN Basic


$89/ 30 days

ATI RN Premium


$150/ 90 days

Similar Questions